Engineering isogenic neuronal models of ATXN3 knockout in Machado-Joseph Disease patient cells by CRISPR/Cas9

被引：0
|
作者：
Fernandes, A. R. [1 ,2 ,3 ]
Adao, D. [1 ,3 ]
Lopes, S. M. [1 ,2 ,3 ]
Henriques, D. [1 ,2 ,3 ]
Pena, F. [1 ,2 ,3 ]
Dias, M. [1 ,3 ]
Santana, M. M. [1 ,2 ,3 ]
Perdigao, P. [1 ,2 ,3 ]
Almeida, L. P. [1 ,3 ,4 ]
机构：
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Inst Interdisciplinary Res, Coimbra, Portugal
[3] Univ Coimbra, Ctr Innovat Biomed & Biotechnol, Coimbra, Portugal
[4] Univ Coimbra, Fac Pharm, Coimbra, Portugal
来源：
HUMAN GENE THERAPY | 2024年 / 35卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P297
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 45 条
  • [1] MODELLING MACHADO-JOSEPH DISEASE IN PATIENT-DERIVED ISOGENIC LINES BY CRISPR/CAS9-MEDIATED CORRETION OF ATXN3-CAG EXPANSION
    Perdigao, Pedro
    Matos, Carlos
    Lopes, Sara
    Fernandes, Rita
    Lopes, Miguel
    Conceicao, Andre
    Faro, Rosario
    Santana, Magda
    Adao, Diana
    Rufino-Ramos, David
    Leandro, Kevin
    Nobre, Rui
    de Almeida, Luis Pereira
    MEDICINE, 2023, 102 (13)
  • [2] Modelling Machado-Joseph Disease in patientderived isogenic lines by CRISPR/Cas9-mediated correction of ATXN3-CAG expansion
    Perdigao, P.
    Matos, C.
    Lopes, S.
    Fernandes, R.
    Lopes, M.
    Conceicao, A.
    Faro, R.
    Santana, M.
    Adao, D.
    Rufino-Ramos, D.
    Leandro, K.
    Nobre, R.
    de Almeida, L. Pereira
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A119 - A119
  • [3] CRISPR-Cas9-Mediated Pre-Transcriptional Silencing of Mutant ATXN3 Decreases Motor Impairments of an In Vivo Machado-Joseph Disease Model
    Matos, Carlos
    Pena, Frederico
    Conceicao, Andre
    Lopes, Sara
    Duarte, Sonia
    Miranda, Catarina
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2019, 27 (04) : 120 - 121
  • [4] Sequence Analysis of 5' Regulatory Regions of the Machado-Joseph Disease Gene (ATXN3)
    Bettencourt, Conceicao
    Raposo, Mafalda
    Kazachkova, Nadiya
    Santos, Cristina
    Kay, Teresa
    Vasconcelos, Joao
    Maciel, Patricia
    Donis, Karina C.
    Saraiva-Pereira, Maria Luiza
    Jardim, Laura B.
    Sequeiros, Jorge
    Bruges-Armas, Jacome
    Lima, Manuela
    CEREBELLUM, 2012, 11 (04): : 1045 - 1050
  • [5] PERMANENT INACTIVATION OF THE ATXN3 GENE: A POSSIBLE THERAPEUTIC APPROACH FOR MACHADO-JOSEPH DISEASE
    Lopes, Sara M.
    Lopes, Miguel M.
    Nobre, Rui J.
    Nobrega, Clevio
    Matos, Carlos A.
    Vasconcelos-Ferreira, Ana
    Sanjana, Neville E.
    Hsu, Patrick D.
    Ann Ran, F.
    Swiech, Lukasz
    Cong, Le
    Zhang, Feng
    de Almeida, Luis Pereira
    MEDICINE, 2021, 100 (04)
  • [6] Increased transcript diversity: novel splicing variants of Machado-Joseph Disease gene (ATXN3)
    Bettencourt, Conceicao
    Santos, Cristina
    Montiel, Rafael
    Costa, Maria do Carmo
    Cruz-Morales, Pablo
    Santos, Liliana Ribeiro
    Simoes, Nelson
    Kay, Teresa
    Vasconcelos, Joao
    Maciel, Patricia
    Lima, Manuela
    NEUROGENETICS, 2010, 11 (02) : 193 - 202
  • [7] Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease
    Naila S. Ashraf
    Sara Duarte-Silva
    Emily D. Shaw
    Patrícia Maciel
    Henry L. Paulson
    Andreia Teixeira-Castro
    Maria do Carmo Costa
    Molecular Neurobiology, 2019, 56 : 3690 - 3701
  • [8] Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease
    Ashraf, Naila S.
    Duarte-Silva, Sara
    Shaw, Emily D.
    Maciel, Patricia
    Paulson, Henry L.
    Teixeira-Castro, Andreia
    Costa, Maria do Carmo
    MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3690 - 3701
  • [9] Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Machado-Joseph Disease
    Leandro, K.
    Rufino-Ramos, D.
    D'Amelio, T.
    Margarida Salgueiro, A.
    Lopes, S.
    Pereira, D.
    Martins, I. M.
    Lobo, D.
    Faro, R.
    Perdigao, P.
    Pereira de Almeida, L.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A179 - A179
  • [10] CRISPR interference-mediated silencing of mutant ATXN3 decreases motor impairments of an in vivo Machado-Joseph disease model
    Matos, Carlos
    Pena, Frederico
    Conceicao, Andre
    Lopes, Sara
    Duarte, Sonia
    Miranda, Catarina
    de Almeida, Luis Pereira
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 86 - 87
12345